ArticleJournal of gynecologic oncology2026

PARP inhibitor maintenance takes advantages in advanced epithelial ovarian cancer but May show a negative impact while recurrence occurs: a multi-center retrospective study in Taiwan.

Wei-Ting Chao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.